$INMD has been on an absolute tear since its IPO during Aug. 2019. Today's price, $176.81, is 1,200%+ higher than its IPO price a little over 2 years ago!

Significant shareholders include Renaissance Technologies, Two Sigma, and Millenium Management. Renaissance and Two Sigma increased their position by 41% and 71%, respectively, during Q2. Millenium increased their position by a whopping 1,694%, although INMD only accounts for 0.02% of their portfolio.

Overall institutional ownership is 60.42% of shares outstanding. More funds added shares than sold shares during Q2, a positive signal.

Signiciant sellers include Point72 and Moore Capital; both funds completely liquidated their position during Q2.

The largest shareholder in terms of portfolio weight is Ariose Capital. $INMD makes up 20.40% of their portfolio and is their largest position.

Thanks to @nathanworden for putting this company on my radar. $INMD has appreciated 84% the past 3 months, making it very hard to buy at a "decent" level relative to moving averages.

I own no position in $INMD